We analyzed the expression of LMNB1 and DLGAP5 in glioma patients with different histological subtype (Figure 3A,B), molecular subtype (Figure 3C,D), progression stage (Figure 3E–H) and IDH status (Figure 3I–L) in TCGA and CGGA databases. Here, LMNB1 is linked to central nervous system cancer.